Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2022).
Revenue
€ 3.5 million
▲ 6% vs 2024
Profit
Growing€ 2.9 million
▲ 1110% vs 2024
Debts
Low€ 14 million
▲ 52% vs 2024
Curium International from Brussel, company number BE0860215596, closed financial year 2025 with a result of € 2.9 million after tax. For that financial year Curium International recorded revenue of € 3.5 million and equity of € 53.4 million. Compared with financial year 2024, the result moved from € -284,425 to € 2.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 3, 2026.
What happened at Curium International?
What happened at Curium International in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Xavier DEFOURT stepped down as director. NBB
- Guillaume TALLANDIER stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.9 million. filed late Source: NBB ↗
- Guillaume TALLANDIER became a director. NBB
- Xavier DEFOURT became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 3.4 million loss in 2021 to € 2.9 million profit in 2025.
Paid € 2.9 million in corporate taxes since 2021.
Best year ever: 2023, with € 5 million profit.
Pays suppliers within 163 days on average.
A new publication or filing at Curium International? We notify you, reason included.
Follow Curium InternationalNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Curium Bidco SARL (100%). It owns 100% of Curium Pet Liège SA, 100% of IBA MOLECULAR TURKEY, 100% of IBA MOLECULAR UK LTD, 100% of Curium Pharma India Private Limited, 75% of BETAPLUS PHARMA SA and 50.3% of Bio Molecular Industries Sdn BHD itself.
Directors
According to the 2025 annual accounts
Guillaume TALLANDIER
Director
since 2023 · until 2027
since 2018 · until 2028
Shareholders
Curium Bidco SARL
100%
Participations
100%
IBA MOLECULAR TURKEY
100%
IBA MOLECULAR UK LTD
100%
Curium Pharma India Private Limited
100%
Bio Molecular Industries Sdn BHD
50.3%
Swan Isotopes AG
5.4%
Curiumpharma Mexico SA de CV
Establishments
Establishment units
Physical locations of this company
Bischoffsheimlaan 39 box 4
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0860.215.596
- VAT number
- BE 0860.215.596
- Registered office
- Bischoffsheimlaan 39 bus 4, 1000 Brussel
- Names & denominations
- Curium International
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 August 2003
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten